| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681615 | Clinical Neurology and Neurosurgery | 2018 | 8 Pages |
Abstract
The expected VAS pain reduction (>50%) from a lidocaine containing transforaminal epidural steroid injection renders it a valuable diagnostic tool in improving clinical outcome after lumbar endoscopic transforaminal decompression.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Kai-Uwe Lewandrowski,